Streetbeat News

Analyst Ratings

VRTX

Morgan Stanley analyst Matthew Harrison has reiterated an Equal-Weight rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raised the price target from $305 to $340.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:10 pm

SPLK

Morgan Stanley analyst Keith Weiss has reiterated an Equal-Weight rating on Splunk (NASDAQ:SPLK) and maintained a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:09 pm

SGTX

Morgan Stanley analyst Matthew Harrison maintains an Equal-Weight rating on Sigilon Therapeutics (NASDAQ:SGTX) and raises the price target from $7 to $21.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:08 pm

PAYX

Morgan Stanley analyst James Faucette has reiterated an Equal-Weight rating on Paychex (NASDAQ:PAYX) and maintained a $125 price target.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:07 pm

NKE

Morgan Stanley analyst Alex Kurtz has maintained an Overweight rating on Nike (NYSE:NKE) but lowered the price target from $130 to $127.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:06 pm

IFF

Morgan Stanley analyst Betsy Graseck has maintained an Overweight rating on Intl Flavors & Fragrances (IFF) but lowered the price target from $122 to $112.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:05 pm

ACCD

Morgan Stanley analyst Ricky Goldwasser has reiterated an Equal-Weight rating on Accolade (NASDAQ:ACCD) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:03 pm

ANET

Arista Networks (NYSE:ANET) has received a mix of bullish and indifferent analyst ratings in the last quarter. The average 12-month price target for the company, according to 11 analysts, is $174.64, which has increased by 6.77% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 1:01 pm

WEAV

Weave Communications (NYSE:WEAV) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 1 indifferent. The average 12-month price target for the company, according to 4 analysts, is $9.5, with a high of $13.00 and a low of $6.00. This average price target has increased by 72.73% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 1:01 pm

CPE

Callon Petroleum (NYSE:CPE) has received 7 analyst ratings in the last quarter, with 4 being bullish and 3 indifferent. The average price target is $51.43, indicating an upside from the current price of $34.91. The average price target has increased by 0.27% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 1:01 pm